Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Keven Hoerster"'
Autor:
Maryam Hejazi, Congcong Zhang, Sabrina B. Bennstein, Vera Balz, Sarah B. Reusing, Melissa Quadflieg, Keven Hoerster, Stefan Heinrichs, Helmut Hanenberg, Sebastian Oberbeck, Marcus Nitsche, Sophie Cramer, Rita Pfeifer, Pranav Oberoi, Heiko Rühl, Johannes Oldenburg, Peter Brossart, Peter A. Horn, Florian Babor, Winfried S. Wels, Johannes C. Fischer, Nina Möker, Markus Uhrberg
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
The generation and expansion of functionally competent NK cells in vitro is of great interest for their application in immunotherapy of cancer. Since CD33 constitutes a promising target for immunotherapy of myeloid malignancies, NK cells expressing a
Externí odkaz:
https://doaj.org/article/4c25f962481b401c9f9ed4e85508f881
Autor:
Keven Hoerster, Markus Uhrberg, Constanze Wiek, Peter A. Horn, Helmut Hanenberg, Stefan Heinrichs
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Cellular immunotherapy using chimeric antigen receptors (CARs) so far has almost exclusively used autologous peripheral blood-derived T cells as immune effector cells. However, harvesting sufficient numbers of T cells is often challenging in heavily
Externí odkaz:
https://doaj.org/article/0287831f3ff941d5a6039e67b90ff70d
Autor:
Miriam Stenzinger, Darja Karpova, Christian Unterrainer, Sabine Harenkamp, Eliza Wiercinska, Keven Hoerster, Martina Pfeffer, Erik Maronde, Halvard Bonig
Publikováno v:
Cells, Vol 8, Iss 9, p 1033 (2019)
Circadian oscillations in circulating leukocyte subsets including immature hematopoietic cells have been appreciated; the origin and nature of these alterations remain elusive. Our analysis of wild-type C57BL/6 mice under constant darkness confirmed
Externí odkaz:
https://doaj.org/article/ab8810ae0efe4da1bf77f8c66859d32a
Autor:
Christian Milde, Luise Roser, Marcel G. E. Rommel, Franziska Schenk, Ute Modlich, Keven Hoerster, Niels Heinz, Saskia Kohlscheen
Publikováno v:
Experimental hematology, 85:33-46
Thrombopoietin (THPO) and its receptor myeloproliferative leukemia virus oncogene (MPL) regulate hematopoietic stem cell (HSC) quiescence and maintenance, but also megakaryopoiesis. Thrombocytopenias or aplastic anemias can be treated today with THPO